As a result of the expected increasing use in reproductive-aged women, close monitoring and proactive pharmacovigilance are warranted [140]
Whole-cell currents were digitally sampled at a frequency of 10 kHz after filtering at 13 kHz
According to the National Library of Medicine, GLP-1 or Glucagon-like-peptide-1 are agonists known to be associated with a class of medications which are utilised to treat type 2 diabetes mellitus (T2DM) and obesity
The following search algorithm was applied: ((GLP-1 receptor agonist OR glucagon-like peptide-1 receptor agonist OR GIP receptor agonist OR glucose-dependent insulinotropic polypeptide OR liraglutide OR semaglutide OR dulaglutide OR tirzepatide) AND (body composition OR fat mass OR muscle mass OR lean mass OR adiposity OR body fat OR sarcopenia)) AND (clinical trial OR study OR randomized controlled trial OR RCT OR intervention study)
This does not influence our rankings or medical evaluations
Turton MD, OShea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, et al